Antimicrobial Urinary Catheters Companies, Corporate Milestones, Corporate Growth

Top Vendors in the Antimicrobial Urinary Catheters Market & Their Offerings

Explore all your Antimicrobial Urinary Catheters Market insights and data in one place - Access the Dashboard Now

Company Offering 2026

Supply Chain Analysis

R&D

• Research and development in antimicrobial urinary catheters focuses on lowering catheter-associated urinary tract infections (CAUTIs), responsible for nearly 70–80% of hospital-acquired UTIs. Current innovations emphasize stronger and longer-lasting antimicrobial coatings for extended use. Companies are increasingly using materials such as silver, antibiotics, and hydrogels to improve infection control.
• Key players: Becton, Dickinson and Company, Medline Industries, ConvaTec Group plc, Well Lead Medical, and Silq Technologies.

Clinical Trials

• Clinical trials for antimicrobial urinary catheters mainly evaluate their ability to lower catheter-associated urinary tract infections (CAUTIs). These studies compare antimicrobial-coated catheters, such as silver-alloy, nitrofurazone, or antibiotic-treated devices, with standard catheters. Many trials report reduced bacterial growth, but results on lowering symptomatic infections remain inconsistent, particularly for long-term use. 
• Key players: Becton, Dickinson and Company, Teleflex Incorporated, ConvaTec Group plc, Medline Industries, and Coloplast A/S.

Patient Support and Services

• Patient support and service programs for antimicrobial urinary catheters focus on ensuring safe use and effective infection prevention. These services include proper catheter insertion, regular maintenance, patient and caregiver education, and timely removal to lower the risk of catheter-associated urinary tract infections (CAUTIs). Such support helps improve patient safety and treatment outcomes.
• Key players: Becton, Dickinson and Company, Coloplast A/S, ConvaTec Group plc, Teleflex Incorporated, and Medline Industries.

Market Growth

The global antimicrobial urinary catheters market size was estimated at USD 1.24 billion in 2025 and is predicted to increase from USD 1.35 billion in 2026 to approximately USD 2.8 billion by 2035, expanding at a CAGR of 8.48% from 2026 to 2035.

What are the Recent Developments in the Antimicrobial Urinary Catheters Market?

• In May 2024, Laborie Medical Technologies reported encouraging two- and five-year clinical study outcomes for its Optilume BPH Catheter System, a minimally invasive treatment designed for benign prostatic hyperplasia. The results, shared at the American Urological Association Annual Meeting in San Antonio, Texas, showed lasting improvements in urinary flow and symptom relief, with a low need for retreatment and no negative effect on sexual function. These findings highlight the company’s ongoing focus on advancing urology treatments through research and innovation.
• In April 2024, Medline Industries formed an exclusive distribution partnership with Consure Medical to supply the QiVi External Urinary Management System. The agreement is intended to strengthen Medline’s urinary care product range and support healthcare providers with improved solutions for managing urinary incontinence in clinical settings.

Get a free customized Antimicrobial Urinary Catheters Market sample with key stats, segments, and competitor insights: Download Free Sample Now